BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ancey PB, Contat C, Meylan E. Glucose transporters in cancer - from tumor cells to the tumor microenvironment. FEBS J 2018;285:2926-43. [PMID: 29893496 DOI: 10.1111/febs.14577] [Cited by in Crossref: 124] [Cited by in F6Publishing: 137] [Article Influence: 31.0] [Reference Citation Analysis]
Number Citing Articles
1 Schmidl S, Ursu O, Iancu CV, Oreb M, Oprea TI, Choe JY. Identification of new GLUT2-selective inhibitors through in silico ligand screening and validation in eukaryotic expression systems. Sci Rep 2021;11:13751. [PMID: 34215797 DOI: 10.1038/s41598-021-93063-5] [Reference Citation Analysis]
2 Pan J, Zang Y. LINC00667 Promotes Progression of Esophageal Cancer Cells by Regulating miR-200b-3p/SLC2A3 Axis. Dig Dis Sci 2021. [PMID: 34313922 DOI: 10.1007/s10620-021-07145-5] [Reference Citation Analysis]
3 Tilekar K, Upadhyay N, Hess JD, Macias LH, Mrowka P, Aguilera RJ, Meyer-Almes FJ, Iancu CV, Choe JY, Ramaa CS. Structure guided design and synthesis of furyl thiazolidinedione derivatives as inhibitors of GLUT 1 and GLUT 4, and evaluation of their anti-leukemic potential. Eur J Med Chem 2020;202:112603. [PMID: 32634629 DOI: 10.1016/j.ejmech.2020.112603] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
4 Antonelli M, Holčapek M, Wolrab D. Ultrahigh-performance supercritical fluid chromatography – mass spectrometry for the qualitative analysis of metabolites covering a large polarity range. Journal of Chromatography A 2022;1665:462832. [DOI: 10.1016/j.chroma.2022.462832] [Reference Citation Analysis]
5 Osumi H, Horiguchi H, Kadomatsu T, Tashiro K, Morinaga J, Takahashi T, Ikeda K, Ito T, Suzuki M, Endo M, Oike Y. Tumor cell-derived angiopoietin-like protein 2 establishes a preference for glycolytic metabolism in lung cancer cells. Cancer Sci 2020;111:1241-53. [PMID: 32012400 DOI: 10.1111/cas.14337] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Zeng Z, Nian Q, Chen N, Zhao M, Zheng Q, Zhang G, Zhao Z, Chen Y, Wang J, Zeng J, Gong D, Tang J. Ginsenoside Rg3 inhibits angiogenesis in gastric precancerous lesions through downregulation of Glut1 and Glut4. Biomed Pharmacother 2021;:112086. [PMID: 34799220 DOI: 10.1016/j.biopha.2021.112086] [Reference Citation Analysis]
7 Xie J, Gonzalez-carter D, Tockary TA, Nakamura N, Xue Y, Nakakido M, Akiba H, Dirisala A, Liu X, Toh K, Yang T, Wang Z, Fukushima S, Li J, Quader S, Tsumoto K, Yokota T, Anraku Y, Kataoka K. Dual-Sensitive Nanomicelles Enhancing Systemic Delivery of Therapeutically Active Antibodies Specifically into the Brain. ACS Nano 2020;14:6729-42. [DOI: 10.1021/acsnano.9b09991] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
8 Orel VE, Ashykhmin A, Golovko T, Rykhalskyi O, Orel VB. Texture Analysis of Tumor and Peritumoral Tissues Based on 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Hybrid Imaging in Patients With Rectal Cancer. J Comput Assist Tomogr 2021;45:820-8. [PMID: 34469907 DOI: 10.1097/RCT.0000000000001218] [Reference Citation Analysis]
9 Wei F, Wang D, Wei J, Tang N, Tang L, Xiong F, Guo C, Zhou M, Li X, Li G, Xiong W, Zhang S, Zeng Z. Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resisitance. Cell Mol Life Sci 2021;78:173-93. [PMID: 32654036 DOI: 10.1007/s00018-020-03581-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
10 Heydarzadeh S, Moshtaghie AA, Daneshpoor M, Hedayati M. Regulators of glucose uptake in thyroid cancer cell lines. Cell Commun Signal. 2020;18:83. [PMID: 32493394 DOI: 10.1186/s12964-020-00586-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
11 Liu X, Zhang Y, Zhuang L, Olszewski K, Gan B. NADPH debt drives redox bankruptcy: SLC7A11/xCT-mediated cystine uptake as a double-edged sword in cellular redox regulation. Genes Dis 2021;8:731-45. [PMID: 34522704 DOI: 10.1016/j.gendis.2020.11.010] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
12 Li X, Sun J, Xu Q, Duan W, Yang L, Wu X, Lu G, Zhang L, Zheng Y. Oxymatrine Inhibits Colorectal Cancer Metastasis via Attenuating PKM2-Mediated Aerobic Glycolysis. Cancer Manag Res 2020;12:9503-13. [PMID: 33061637 DOI: 10.2147/CMAR.S267686] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Glorieux C, Buc Calderon P. Vitamin C (Ascorbate) and Redox Topics in Cancer. Antioxid Redox Signal 2021. [PMID: 34254829 DOI: 10.1089/ars.2020.8233] [Reference Citation Analysis]
14 Zhang X, Li J, Ghoshal K, Fernandez S, Li L. Identification of a Subtype of Hepatocellular Carcinoma with Poor Prognosis Based on Expression of Genes within the Glucose Metabolic Pathway. Cancers (Basel) 2019;11:E2023. [PMID: 31847435 DOI: 10.3390/cancers11122023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
15 Chang SM, Vander Heiden MG. Inhibiting GLUTtony in cancer. Cell Chem Biol 2022;29:353-5. [PMID: 35303439 DOI: 10.1016/j.chembiol.2022.03.004] [Reference Citation Analysis]
16 Parsons RB, Facey PD. Nicotinamide N-Methyltransferase: An Emerging Protagonist in Cancer Macro(r)evolution. Biomolecules 2021;11:1418. [PMID: 34680055 DOI: 10.3390/biom11101418] [Reference Citation Analysis]
17 Li Z, Geng J, Xie B, He J, Wang J, Peng L, Hu Y, Dai H, Wang C. Dihydromyricetin Alleviates Pulmonary Fibrosis by Regulating Abnormal Fibroblasts Through the STAT3/p-STAT3/GLUT1 Signaling Pathway. Front Pharmacol 2022;13:834604. [DOI: 10.3389/fphar.2022.834604] [Reference Citation Analysis]
18 Poturnajova M, Furielova T, Balintova S, Schmidtova S, Kucerova L, Matuskova M. Molecular features and gene expression signature of metastatic colorectal cancer (Review). Oncol Rep 2021;45:10. [PMID: 33649827 DOI: 10.3892/or.2021.7961] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Echeverría C, Nualart F, Ferrada L, Smith GJ, Godoy AS. Hexose Transporters in Cancer: From Multifunctionality to Diagnosis and Therapy. Trends in Endocrinology & Metabolism 2021;32:198-211. [DOI: 10.1016/j.tem.2020.12.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
20 Pan T, Liu J, Xu S, Yu Q, Wang H, Sun H, Wu J, Zhu Y, Zhou J, Zhu Y. ANKRD22, a novel tumor microenvironment-induced mitochondrial protein promotes metabolic reprogramming of colorectal cancer cells. Theranostics 2020;10:516-36. [PMID: 31903135 DOI: 10.7150/thno.37472] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
21 Liu C, Jin Y, Fan Z. The Mechanism of Warburg Effect-Induced Chemoresistance in Cancer. Front Oncol 2021;11:698023. [PMID: 34540667 DOI: 10.3389/fonc.2021.698023] [Reference Citation Analysis]
22 Muñoz-Montesino C, Peña E, Roa FJ, Sotomayor K, Escobar E, Rivas CI. Transport of Vitamin C in Cancer. Antioxid Redox Signal 2021;35:61-74. [PMID: 33607936 DOI: 10.1089/ars.2020.8166] [Reference Citation Analysis]
23 Scully T, Ettela A, LeRoith D, Gallagher EJ. Obesity, Type 2 Diabetes, and Cancer Risk. Front Oncol 2020;10:615375. [PMID: 33604295 DOI: 10.3389/fonc.2020.615375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Mori K, Miura N, Mostafaei H, Quhal F, Motlagh RS, Lysenko I, Kimura S, Egawa S, Karakiewicz PI, Shariat SF. Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis. Int J Clin Oncol 2020;25:1459-74. [PMID: 32451768 DOI: 10.1007/s10147-020-01690-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
25 Mobet Y, Liu X, Liu T, Yu J, Yi P. Interplay Between m6A RNA Methylation and Regulation of Metabolism in Cancer. Front Cell Dev Biol 2022;10:813581. [DOI: 10.3389/fcell.2022.813581] [Reference Citation Analysis]
26 Seth Nanda C, Venkateswaran SV, Patani N, Yuneva M. Defining a metabolic landscape of tumours: genome meets metabolism. Br J Cancer 2020;122:136-49. [PMID: 31819196 DOI: 10.1038/s41416-019-0663-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
27 Fu J, Yang J, Seeberger PH, Yin J. Glycoconjugates for glucose transporter-mediated cancer-specific targeting and treatment. Carbohydr Res 2020;498:108195. [PMID: 33220603 DOI: 10.1016/j.carres.2020.108195] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
28 Golubev AG, Anisimov VN. Aging and cancer: Is glucose a mediator between them? Oncotarget 2019;10:6758-67. [PMID: 31827719 DOI: 10.18632/oncotarget.27344] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
29 Ciarimboli G, Theil G, Bialek J, Edemir B. Contribution and Expression of Organic Cation Transporters and Aquaporin Water Channels in Renal Cancer. Rev Physiol Biochem Pharmacol 2020. [PMID: 32772272 DOI: 10.1007/112_2020_34] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Ferreira RS, Pons JL, Labesse G. Insights into Substrate and Inhibitor Selectivity among Human GLUT Transporters through Comparative Modeling and Molecular Docking. ACS Omega 2019;4:4748-60. [PMID: 32462103 DOI: 10.1021/acsomega.8b03447] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
31 Lu W, Cao F, Wang S, Sheng X, Ma J. LncRNAs: The Regulator of Glucose and Lipid Metabolism in Tumor Cells. Front Oncol 2019;9:1099. [PMID: 31850189 DOI: 10.3389/fonc.2019.01099] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
32 Zhuo M, Gorgun FM, Tyler DS, Englander EW. Hypoxia potentiates the capacity of melanoma cells to evade cisplatin and doxorubicin cytotoxicity via glycolytic shift. FEBS Open Bio 2020;10:789-801. [PMID: 32134564 DOI: 10.1002/2211-5463.12830] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
33 Zhelev Z, Aoki I, Lazarova D, Vlaykova T, Higashi T, Bakalova R, Giudetti AM. A “Weird” Mitochondrial Fatty Acid Oxidation as a Metabolic “Secret” of Cancer. Oxidative Medicine and Cellular Longevity 2022;2022:1-38. [DOI: 10.1155/2022/2339584] [Reference Citation Analysis]
34 Lv X, Li R, Li Z, Wang J. Purification of Gekko Small Peptide Fraction and Its Effect of Inducing Apoptosis of EC 9706 Esophageal Cancer Cells by Inhibiting PI3K/Akt/GLUT1 Signaling Pathway. Chem Biodivers 2021;18:e2000720. [PMID: 33534194 DOI: 10.1002/cbdv.202000720] [Reference Citation Analysis]
35 Olszewski K, Barsotti A, Feng XJ, Momcilovic M, Liu KG, Kim JI, Morris K, Lamarque C, Gaffney J, Yu X, Patel JP, Rabinowitz JD, Shackelford DB, Poyurovsky MV. Inhibition of glucose transport synergizes with chemical or genetic disruption of mitochondrial metabolism and suppresses TCA cycle-deficient tumors. Cell Chem Biol 2021:S2451-9456(21)00441-4. [PMID: 34715056 DOI: 10.1016/j.chembiol.2021.10.007] [Reference Citation Analysis]
36 Long N, Peng S, Chu L, Jia J, Dong M, Liu J. Paclitaxel inhibits the migration of CD133+ U251 malignant glioma cells by reducing the expression of glycolytic enzymes. Exp Ther Med 2020;20:72. [PMID: 32963602 DOI: 10.3892/etm.2020.9200] [Reference Citation Analysis]
37 Ma DB, Qin MM, Shi L, Ding XM. MicroRNA-6077 enhances the sensitivity of patients-derived lung adenocarcinoma cells to anlotinib by repressing the activation of glucose transporter 1 pathway. Cell Signal 2019;64:109391. [PMID: 31421224 DOI: 10.1016/j.cellsig.2019.109391] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
38 Pizzagalli MD, Bensimon A, Superti-Furga G. A guide to plasma membrane solute carrier proteins. FEBS J 2021;288:2784-835. [PMID: 32810346 DOI: 10.1111/febs.15531] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
39 Zhou D, Jiang L, Jin L, Yao Y, Wang P, Zhu X. Glucose Transporter-1 Cooperating with AKT Signaling Promote Gastric Cancer Progression. Cancer Manag Res 2020;12:4151-60. [PMID: 32581586 DOI: 10.2147/CMAR.S251596] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
40 Cao S, Chen Y, Ren Y, Feng Y, Long S. GLUT1 biological function and inhibition: research advances. Future Med Chem 2021;13:1227-43. [PMID: 34018847 DOI: 10.4155/fmc-2021-0071] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Maaßen T, Vardanyan S, Brosig A, Merz H, Ranjbar M, Kakkassery V, Grisanti S, Tura A. Monosomy-3 Alters the Expression Profile of the Glucose Transporters GLUT1-3 in Uveal Melanoma. Int J Mol Sci 2020;21:E9345. [PMID: 33302435 DOI: 10.3390/ijms21249345] [Reference Citation Analysis]
42 Demény MA, Virág L. The PARP Enzyme Family and the Hallmarks of Cancer Part 1. Cell Intrinsic Hallmarks. Cancers (Basel) 2021;13:2042. [PMID: 33922595 DOI: 10.3390/cancers13092042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
43 Cheng Z, Luo C, Guo Z. LncRNA-XIST/microRNA-126 sponge mediates cell proliferation and glucose metabolism through the IRS1/PI3K/Akt pathway in glioma. J Cell Biochem 2020;121:2170-83. [PMID: 31680298 DOI: 10.1002/jcb.29440] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
44 Kang H, Lee S, Kim K, Jeon J, Kang SG, Youn H, Kim HY, Youn B. Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma. J Exp Clin Cancer Res 2021;40:282. [PMID: 34488821 DOI: 10.1186/s13046-021-02077-4] [Reference Citation Analysis]
45 Kreitz J, Schönfeld C, Seibert M, Stolp V, Alshamleh I, Oellerich T, Steffen B, Schwalbe H, Schnütgen F, Kurrle N, Serve H. Metabolic Plasticity of Acute Myeloid Leukemia. Cells 2019;8:E805. [PMID: 31370337 DOI: 10.3390/cells8080805] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 14.7] [Reference Citation Analysis]
46 Zhang Z, Li X, Yang F, Chen C, Liu P, Ren Y, Sun P, Wang Z, You Y, Zeng YX, Li X. DHHC9-mediated GLUT1 S-palmitoylation promotes glioblastoma glycolysis and tumorigenesis. Nat Commun 2021;12:5872. [PMID: 34620861 DOI: 10.1038/s41467-021-26180-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Siltari A, Auvinen A, Murtola TJ. Pharmacoepidemiological Evaluation in Prostate Cancer-Common Pitfalls and How to Avoid Them. Cancers (Basel) 2021;13:696. [PMID: 33572236 DOI: 10.3390/cancers13040696] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Kataoka H, Nishie H, Tanaka M, Sasaki M, Nomoto A, Osaki T, Okamoto Y, Yano S. Potential of Photodynamic Therapy Based on Sugar-Conjugated Photosensitizers. J Clin Med 2021;10:841. [PMID: 33670714 DOI: 10.3390/jcm10040841] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
49 Yu Y, Feng C, Kuang J, Guo L, Guan H. Metformin exerts an antitumoral effect on papillary thyroid cancer cells through altered cell energy metabolism and sensitized by BACH1 depletion. Endocrine 2022. [PMID: 35050486 DOI: 10.1007/s12020-021-02977-7] [Reference Citation Analysis]
50 Chen X, Zhao Y, Gao Y, Qi Y, Du J. Outcomes in hepatocellular carcinoma patients undergoing sorafenib treatment: toxicities, cellular oxidative stress, treatment adherence, and quality of life: Erratum. Anticancer Drugs 2021;32:345-64. [PMID: 33417326 DOI: 10.1097/CAD.0000000000001029] [Reference Citation Analysis]
51 Visavadiya NP, Rossiter HB, Khamoui AV. Distinct glycolytic pathway regulation in liver, tumour and skeletal muscle of mice with cancer cachexia. Cell Biochem Funct 2021;39:802-12. [PMID: 34129243 DOI: 10.1002/cbf.3652] [Reference Citation Analysis]
52 Pliszka M, Szablewski L. Glucose Transporters as a Target for Anticancer Therapy. Cancers (Basel) 2021;13:4184. [PMID: 34439338 DOI: 10.3390/cancers13164184] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Han W, Shi J, Cao J, Dong B, Guan W. Emerging Roles and Therapeutic Interventions of Aerobic Glycolysis in Glioma. Onco Targets Ther 2020;13:6937-55. [PMID: 32764985 DOI: 10.2147/OTT.S260376] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
54 Miao J, Zhang L, Gao P, Zhao H, Xie X, Wang J. Chitosan-Based Glycolipid Conjugated siRNA Delivery System for Improving Radiosensitivity of Laryngocarcinoma. Polymers (Basel) 2021;13:2929. [PMID: 34502969 DOI: 10.3390/polym13172929] [Reference Citation Analysis]
55 Kawatani M, Aono H, Hiranuma S, Shimizu T, Muroi M, Ogawa N, Ohishi T, Ohba SI, Kawada M, Nogawa T, Okano A, Hashizume D, Osada H. Identification of a Small-Molecule Glucose Transporter Inhibitor, Glutipyran, That Inhibits Cancer Cell Growth. ACS Chem Biol 2021. [PMID: 34296611 DOI: 10.1021/acschembio.1c00480] [Reference Citation Analysis]
56 Seo Y, Kim YW, Lee D, Kim D, Kim K, Kim T, Baek C, Lee Y, Lee J, Lee H, Jang G, Jeong W, Choi J, Hwang D, Suh JS, Kim SW, Kim HK, Han J, Bang H, Kim JH, Zhou T, Ko JH. Far-infrared rays enhance mitochondrial biogenesis and GLUT3 expression under low glucose conditions in rat skeletal muscle cells. Korean J Physiol Pharmacol 2021;25:167-75. [PMID: 33602887 DOI: 10.4196/kjpp.2021.25.2.167] [Reference Citation Analysis]
57 Shuvalov O, Daks A, Fedorova O, Petukhov A, Barlev N. Linking Metabolic Reprogramming, Plasticity and Tumor Progression. Cancers (Basel) 2021;13:762. [PMID: 33673109 DOI: 10.3390/cancers13040762] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
58 Zhu Y, Ferri-Borgogno S, Sheng J, Yeung TL, Burks JK, Cappello P, Jazaeri AA, Kim JH, Han GH, Birrer MJ, Mok SC, Wong STC. SIO: A Spatioimageomics Pipeline to Identify Prognostic Biomarkers Associated with the Ovarian Tumor Microenvironment. Cancers (Basel) 2021;13:1777. [PMID: 33917869 DOI: 10.3390/cancers13081777] [Reference Citation Analysis]
59 Grega T, Vojtechova G, Gregova M, Zavoral M, Suchanek S. Pathophysiological Characteristics Linking Type 2 Diabetes Mellitus and Colorectal Neoplasia. Physiol Res 2021;70:509-22. [PMID: 34062073 DOI: 10.33549/physiolres.934631] [Reference Citation Analysis]
60 Llinàs-Arias P, Rosselló-Tortella M, López-Serra P, Pérez-Salvia M, Setién F, Marin S, Muñoz JP, Junza A, Capellades J, Calleja-Cervantes ME, Ferreira HJ, de Moura MC, Srbic M, Martínez-Cardús A, de la Torre C, Villanueva A, Cascante M, Yanes O, Zorzano A, Moutinho C, Esteller M. Epigenetic loss of the endoplasmic reticulum-associated degradation inhibitor SVIP induces cancer cell metabolic reprogramming. JCI Insight 2019;5:125888. [PMID: 30843871 DOI: 10.1172/jci.insight.125888] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
61 Zhang Q, Zhao G, Yang N, Zhang L. Fasting blood glucose levels in patients with different types of diseases. Prog Mol Biol Transl Sci 2019;162:277-92. [PMID: 30905457 DOI: 10.1016/bs.pmbts.2019.01.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
62 Yang L, Pei L, Yi J. LINC00839 Regulates Proliferation, Migration, Invasion, Apoptosis and Glycolysis in Neuroblastoma Cells Through miR-338-3p/GLUT1 Axis. Neuropsychiatr Dis Treat 2021;17:2027-40. [PMID: 34188473 DOI: 10.2147/NDT.S309467] [Reference Citation Analysis]
63 Liu X, Olszewski K, Zhang Y, Lim EW, Shi J, Zhang X, Zhang J, Lee H, Koppula P, Lei G, Zhuang L, You MJ, Fang B, Li W, Metallo CM, Poyurovsky MV, Gan B. Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer. Nat Cell Biol 2020;22:476-86. [PMID: 32231310 DOI: 10.1038/s41556-020-0496-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 17.5] [Reference Citation Analysis]
64 Narumi A, Rachi R, Yamazaki H, Kawaguchi S, Kikuchi M, Konno H, Osaki T, Okamoto Y, Shen X, Kakuchi T, Kataoka H, Nomoto A, Yoshimura T, Yano S. Maltotriose-Chlorin e6 Conjugate Linked via Tetraethyleneglycol as an Advanced Photosensitizer for Photodynamic Therapy. Synthesis and Antitumor Activities against Canine and Mouse Mammary Carcinoma Cells. ACS Omega 2021;6:7023-33. [PMID: 33748616 DOI: 10.1021/acsomega.0c06316] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Ma Y, Wang W, Idowu MO, Oh U, Wang XY, Temkin SM, Fang X. Ovarian Cancer Relies on Glucose Transporter 1 to Fuel Glycolysis and Growth: Anti-Tumor Activity of BAY-876. Cancers (Basel) 2018;11:E33. [PMID: 30602670 DOI: 10.3390/cancers11010033] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 8.5] [Reference Citation Analysis]
66 Hong ZF, Zhang WQ, Wang SJ, Li SY, Shang J, Liu F, Shen DY. Upregulation of DPY30 promotes cell proliferation and predicts a poor prognosis in cholangiocarcinoma. Biomed Pharmacother 2020;123:109766. [PMID: 31846841 DOI: 10.1016/j.biopha.2019.109766] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
67 Luo J, Wang H, Wang L, Wang G, Yao Y, Xie K, Li X, Xu L, Shen Y, Ren B. lncRNA GAS6-AS1 inhibits progression and glucose metabolism reprogramming in LUAD via repressing E2F1-mediated transcription of GLUT1. Mol Ther Nucleic Acids 2021;25:11-24. [PMID: 34141461 DOI: 10.1016/j.omtn.2021.04.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Szabó E, Kulin A, Korányi L, Literáti-Nagy B, Cserepes J, Somogyi A, Sarkadi B, Várady G. Alterations in erythrocyte membrane transporter expression levels in type 2 diabetic patients. Sci Rep 2021;11:2765. [PMID: 33531564 DOI: 10.1038/s41598-021-82417-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Zhang ZJ, Huang YP, Li XX, Liu ZT, Liu K, Deng XF, Xiong L, Zou H, Wen Y. A Novel Ferroptosis-Related 4-Gene Prognostic Signature for Cholangiocarcinoma and Photodynamic Therapy. Front Oncol 2021;11:747445. [PMID: 34712611 DOI: 10.3389/fonc.2021.747445] [Reference Citation Analysis]
70 Azizi MIHN, Othman I, Naidu R. The Role of MicroRNAs in Lung Cancer Metabolism. Cancers (Basel) 2021;13:1716. [PMID: 33916349 DOI: 10.3390/cancers13071716] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Godfrey J, Riscal R, Skuli N, Simon MC. Glucagon signaling via supraphysiologic GCGR can reduce cell viability without stimulating gluconeogenic gene expression in liver cancer cells. Cancer Metab 2022;10. [DOI: 10.1186/s40170-022-00280-1] [Reference Citation Analysis]
72 Vyas M, Patel N, Celli R, Wajapeyee N, Jain D, Zhang X. Glucose Metabolic Reprogramming and Cell Proliferation Arrest in Colorectal Micropapillary Carcinoma. Gastroenterology Res. 2019;12:128-134. [PMID: 31236153 DOI: 10.14740/gr1145] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
73 Kuzyk CL, Anderson CC, Roede JR. Simvastatin Induces Delayed Apoptosis Through Disruption of Glycolysis and Mitochondrial Impairment in Neuroblastoma Cells. Clin Transl Sci 2020;13:563-72. [PMID: 31917509 DOI: 10.1111/cts.12740] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
74 Jaiswara PK, Kumar A. Nimbolide retards T cell lymphoma progression by altering apoptosis, glucose metabolism, pH regulation, and ROS homeostasis. Environ Toxicol 2022. [PMID: 35199915 DOI: 10.1002/tox.23497] [Reference Citation Analysis]
75 Beilerli A, Gareev I, Beylerli O, Yang G, Pavlov V, Aliev G, Ahmad A. Circular RNAs as biomarkers and therapeutic targets in cancer. Semin Cancer Biol 2021:S1044-579X(21)00004-3. [PMID: 33434640 DOI: 10.1016/j.semcancer.2020.12.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
76 Zhang Y, Wang J. Targeting uptake transporters for cancer imaging and treatment. Acta Pharm Sin B 2020;10:79-90. [PMID: 31993308 DOI: 10.1016/j.apsb.2019.12.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
77 Chen X, Yu J, Tian H, Shan Z, Liu W, Pan Z, Ren J. Circle RNA hsa_circRNA_100290 serves as a ceRNA for miR-378a to regulate oral squamous cell carcinoma cells growth via Glucose transporter-1 (GLUT1) and glycolysis. J Cell Physiol 2019;234:19130-40. [PMID: 31187488 DOI: 10.1002/jcp.28692] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 16.0] [Reference Citation Analysis]
78 Li S, Wen L, Hu X, Wei Q, Dong Z. HIF in Nephrotoxicity during Cisplatin Chemotherapy: Regulation, Function and Therapeutic Potential. Cancers (Basel) 2021;13:E180. [PMID: 33430279 DOI: 10.3390/cancers13020180] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
79 Gao HF, Chen LY, Cheng CS, Chen H, Meng ZQ, Chen Z. SLC5A1 promotes growth and proliferation of pancreatic carcinoma via glucose-dependent AMPK/mTOR signaling. Cancer Manag Res 2019;11:3171-85. [PMID: 31114359 DOI: 10.2147/CMAR.S195424] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
80 Tan Q, Duan L, Huang Q, Chen W, Yang Z, Chen J, Jin Y. Interleukin -1β Promotes Lung Adenocarcinoma Growth and Invasion Through Promoting Glycolysis via p38 Pathway. J Inflamm Res 2021;14:6491-509. [PMID: 34880649 DOI: 10.2147/JIR.S319433] [Reference Citation Analysis]
81 Assali M, Kittana N, Dayyeh S, Khiar N. Dual covalent functionalization of single-walled carbon nanotubes for effective targeted cancer therapy. Nanotechnology 2021;32:205101. [PMID: 33561838 DOI: 10.1088/1361-6528/abe48c] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
82 Tang B, Xu W, Wang Y, Zhu J, Wang H, Tu J, Weng Q, Kong C, Yang Y, Qiu R, Zhao Z, Xu M, Ji J. Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic death. Clin Immunol 2021;232:108872. [PMID: 34648954 DOI: 10.1016/j.clim.2021.108872] [Reference Citation Analysis]
83 Kamada S, Takeiwa T, Ikeda K, Horie-Inoue K, Inoue S. Long Non-coding RNAs Involved in Metabolic Alterations in Breast and Prostate Cancers. Front Oncol 2020;10:593200. [PMID: 33123488 DOI: 10.3389/fonc.2020.593200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
84 Arizmendi-Izazaga A, Navarro-Tito N, Jiménez-Wences H, Mendoza-Catalán MA, Martínez-Carrillo DN, Zacapala-Gómez AE, Olea-Flores M, Dircio-Maldonado R, Torres-Rojas FI, Soto-Flores DG, Illades-Aguiar B, Ortiz-Ortiz J. Metabolic Reprogramming in Cancer: Role of HPV 16 Variants. Pathogens 2021;10:347. [PMID: 33809480 DOI: 10.3390/pathogens10030347] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Xiong S, Li D, Wang D, Huang L, Liang G, Wu Z, Long J, Yang D, Teng Y, Lei S, Li Y. Circular RNA MYLK Promotes Glycolysis and Proliferation of Non-Small Cell Lung Cancer Cells by Sponging miR-195-5p and Increasing Glucose Transporter Member 3 Expression. Cancer Manag Res 2020;12:5469-78. [PMID: 32753964 DOI: 10.2147/CMAR.S257386] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
86 Mboge MY, Chen Z, Khokhar D, Wolff A, Ai L, Heldermon CD, Bozdag M, Carta F, Supuran CT, Brown KD, McKenna R, Frost CJ, Frost SC. A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells. Biochem J 2019;476:1497-513. [PMID: 31072911 DOI: 10.1042/BCJ20190177] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
87 Roa FJ, Peña E, Gatica M, Escobar-Acuña K, Saavedra P, Maldonado M, Cuevas ME, Moraga-Cid G, Rivas CI, Muñoz-Montesino C. Therapeutic Use of Vitamin C in Cancer: Physiological Considerations. Front Pharmacol 2020;11:211. [PMID: 32194425 DOI: 10.3389/fphar.2020.00211] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
88 Zhao H, Li Y. Cancer metabolism and intervention therapy. Mol Biomed 2021;2:5. [PMID: 35006438 DOI: 10.1186/s43556-020-00012-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
89 Wang Z, Lin X, Chi D, Xu Z, Lin G, Liu H, Sun J, He Z, Wang Y. Single-ligand dual-targeting irinotecan liposomes: Control of targeting ligand display by pH-responsive PEG-shedding strategy to enhance tumor-specific therapy and attenuate toxicity. International Journal of Pharmaceutics 2020;587:119680. [DOI: 10.1016/j.ijpharm.2020.119680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Wedegaertner H, Pan WA, Gonzalez CC, Gonzalez DJ, Trejo J. The α-arrestin ARRDC3 is an Emerging Multifunctional Adaptor Protein in Cancer. Antioxid Redox Signal 2021. [PMID: 34465145 DOI: 10.1089/ars.2021.0193] [Reference Citation Analysis]
91 Xu Y, Zhou X, Zhang S, Nanding A, Xuan Q. Expression and Prognostic Value of Glucose Transporter 3 in Diffuse Large B Cell Lymphoma. OTT 2022;Volume 15:181-91. [DOI: 10.2147/ott.s338826] [Reference Citation Analysis]
92 Shan L, Fan W, Wang W, Tang W, Yang Z, Wang Z, Liu Y, Shen Z, Dai Y, Cheng S, Jacobson O, Zhai K, Hu J, Ma Y, Kiesewetter DO, Gao G, Chen X. Organosilica-Based Hollow Mesoporous Bilirubin Nanoparticles for Antioxidation-Activated Self-Protection and Tumor-Specific Deoxygenation-Driven Synergistic Therapy. ACS Nano 2019;13:8903-16. [DOI: 10.1021/acsnano.9b02477] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 10.3] [Reference Citation Analysis]
93 Farhan M, Silva M, Xingan X, Huang Y, Zheng W. Role of FOXO Transcription Factors in Cancer Metabolism and Angiogenesis. Cells 2020;9:E1586. [PMID: 32629884 DOI: 10.3390/cells9071586] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
94 Mal’shakova MV, Rasova EE, Velegzhaninov IO, Belykh DV. Synthesis of novel chlorophyll a derivatives bearing glucose moieties and estimation of their photocytotoxic activity. Russ Chem Bull 2022;71:531-7. [DOI: 10.1007/s11172-022-3444-z] [Reference Citation Analysis]
95 Brustolin L, Pettenuzzo N, Nardon C, Quarta S, Montagner I, Pontisso P, Rosato A, Conte P, Merigliano S, Fregona D. Labelled micelles for the delivery of cytotoxic Cu(II) and Ru(III) compounds in the treatment of aggressive orphan cancers: Design and biological in vitro data. J Inorg Biochem 2020;213:111259. [PMID: 33039747 DOI: 10.1016/j.jinorgbio.2020.111259] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
96 Li Y, Li H, Wang W, Yu X, Xu Q. LINC00346 regulates glycolysis by modulation of glucose transporter 1 in breast cancer cells. Mol Cell Probes 2020;54:101667. [PMID: 32946972 DOI: 10.1016/j.mcp.2020.101667] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
97 Tyagi K, Mandal S, Roy A. Recent advancements in therapeutic targeting of the Warburg effect in refractory ovarian cancer: A promise towards disease remission. Biochim Biophys Acta Rev Cancer 2021;1876:188563. [PMID: 33971276 DOI: 10.1016/j.bbcan.2021.188563] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Nakazato K, Mogushi K, Kayamori K, Tsuchiya M, Takahashi KI, Sumino J, Michi Y, Yoda T, Uzawa N. Glucose metabolism changes during the development and progression of oral tongue squamous cell carcinomas. Oncol Lett 2019;18:1372-80. [PMID: 31423200 DOI: 10.3892/ol.2019.10420] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
99 Jaiswara PK, Gupta VK, Sonker P, Rawat SG, Tiwari RK, Pathak C, Kumar S, Kumar A. Nimbolide induces cell death in T lymphoma cells: Implication of altered apoptosis and glucose metabolism. Environ Toxicol 2021;36:628-41. [PMID: 33274819 DOI: 10.1002/tox.23067] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
100 Li R, Guo N, Fu L, Miao Y. A Feasible Strategy of Fabricating Redox-Responsive Polymeric Salinomycin Small Molecule Prodrug Delivery for Liver Cancer Therapy. J Clust Sci. [DOI: 10.1007/s10876-022-02249-y] [Reference Citation Analysis]
101 Farhadi P, Yarani R, Valipour E, Kiani S, Hoseinkhani Z, Mansouri K. Cell line-directed breast cancer research based on glucose metabolism status. Biomed Pharmacother 2021;146:112526. [PMID: 34906774 DOI: 10.1016/j.biopha.2021.112526] [Reference Citation Analysis]
102 Suzuki K, Miura Y, Mochida Y, Miyazaki T, Toh K, Anraku Y, Melo V, Liu X, Ishii T, Nagano O, Saya H, Cabral H, Kataoka K. Glucose transporter 1-mediated vascular translocation of nanomedicines enhances accumulation and efficacy in solid tumors. Journal of Controlled Release 2019;301:28-41. [DOI: 10.1016/j.jconrel.2019.02.021] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
103 Mori Y, Yamawaki K, Ishiguro T, Yoshihara K, Ueda H, Sato A, Ohata H, Yoshida Y, Minamino T, Okamoto K, Enomoto T. ALDH-Dependent Glycolytic Activation Mediates Stemness and Paclitaxel Resistance in Patient-Derived Spheroid Models of Uterine Endometrial Cancer. Stem Cell Reports 2019;13:730-46. [PMID: 31564647 DOI: 10.1016/j.stemcr.2019.08.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
104 Zhou L, Li S, Liu L, Zhou Q, Yuan Y, Xin L. [Recombinant methioninase regulates PI3K/Akt/Glut-1 pathway and inhibits aerobic glycolysis to promote apoptosis of gastric cancer cells]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:27-33. [PMID: 32376548 DOI: 10.12122/j.issn.1673-4254.2020.01.05] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
105 Liu Y, Liu C, Zhang H, Yi X, Yu A. Establishment of A Nomogram for Predicting the Prognosis of Soft Tissue Sarcoma Based on Seven Glycolysis-Related Gene Risk Score. Front Genet 2021;12:675865. [PMID: 34925434 DOI: 10.3389/fgene.2021.675865] [Reference Citation Analysis]
106 Zhang X, Pang X, Zhang Z, Liu Q, Zhang H, Xiang Q, Cui Y. Co-expression and prognosis analyses of GLUT1-4 and RB1 in breast cancer. BMC Cancer 2021;21:1026. [PMID: 34525987 DOI: 10.1186/s12885-021-08763-y] [Reference Citation Analysis]
107 Cao H, Qi W, Gao X, Wu Q, Tian L, Wu W. Graphene Quantum Dots prepared by Electron Beam Irradiation for Safe Fluorescence Imaging of Tumor. Nanotheranostics 2022;6:205-14. [PMID: 34976595 DOI: 10.7150/ntno.67070] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Tilekar K, Upadhyay N, Iancu CV, Pokrovsky V, Choe JY, Ramaa CS. Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer. Biochim Biophys Acta Rev Cancer. 2020;1874:188457. [PMID: 33096154 DOI: 10.1016/j.bbcan.2020.188457] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
109 Kalbkhani F, Pirnejad A, Sam S, Sam MR. The Safe Soluble Compound Dehydroascorbic Acid Inhibits Various Upstream and Downstream Effectors of PI3K and KRAS Signaling Pathways in Undruggable PIK3CA/KRAS-Mutant Colorectal Cancer Stem-Like Cells. Nutr Cancer 2020;:1-16. [PMID: 33283545 DOI: 10.1080/01635581.2020.1856387] [Reference Citation Analysis]
110 Wu X, Xiao Y, Ma J, Wang A. Circular RNA: A novel potential biomarker for skin diseases. Pharmacol Res 2020;158:104841. [PMID: 32404296 DOI: 10.1016/j.phrs.2020.104841] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
111 Bächle F, Maichle-Mössmer C, Ziegler T. Helical Self-Assembly of Optically Active Glycoconjugated Phthalocyanine J-Aggregates. Chempluschem 2019;84:1081-93. [PMID: 31943966 DOI: 10.1002/cplu.201900381] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
112 Song G, Lu Q, Fan H, Zhang X, Ge L, Tian R, Wang S, Feng T, Pan J, Feng J, Xiao Y, Yi X, Ren N, Wang L. Inhibition of hexokinases holds potential as treatment strategy for rheumatoid arthritis. Arthritis Res Ther 2019;21:87. [PMID: 30944034 DOI: 10.1186/s13075-019-1865-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
113 Cannistraci A, Hascoet P, Ali A, Mundra P, Clarke NW, Pavet V, Marais R. MiR-378a inhibits glucose metabolism by suppressing GLUT1 in prostate cancer. Oncogene 2022. [PMID: 35039635 DOI: 10.1038/s41388-022-02178-0] [Reference Citation Analysis]
114 Karamali N, Ebrahimnezhad S, Khaleghi Moghadam R, Daneshfar N, Rezaiemanesh A. HRD1 in human malignant neoplasms: Molecular mechanisms and novel therapeutic strategy for cancer. Life Sci 2022;301:120620. [PMID: 35533759 DOI: 10.1016/j.lfs.2022.120620] [Reference Citation Analysis]
115 Braun LA, Varpetyan EE, Zav’yalov GA, Kulikov FV, Marievskii VE, Tyul’ganova DA, Shishnenko AO, Stepanova DS, Shimanovskii NL. Metabolic Enzymes: New Targets for the Design of Antitumor Drugs. Pharm Chem J 2020;54:547-54. [DOI: 10.1007/s11094-020-02238-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
116 Kuramoto K, He C. Degradative and Non-Degradative Roles of Autophagy Proteins in Metabolism and Metabolic Diseases. Front Cell Dev Biol 2022;10:844481. [DOI: 10.3389/fcell.2022.844481] [Reference Citation Analysis]
117 Cvjetinović Đ, Milanović Z, Mirković M, Petrović J, Vesković A, Popović-bijelić A, Prijović Ž, Janković D, Vranješ-đurić S. Magnetically induced controlled release from glucose-modified liposomes loaded with Fe3O4 nanoparticles. J Nanopart Res 2021;23. [DOI: 10.1007/s11051-021-05375-2] [Reference Citation Analysis]
118 Yang JW, Yuan LL, Gao Y, Liu XS, Wang YJ, Zhou LM, Kui XY, Li XH, Ke CB, Pei ZJ. 18F-FDG PET/CT metabolic parameters correlate with EIF2S2 expression status in colorectal cancer. J Cancer 2021;12:5838-47. [PMID: 34475997 DOI: 10.7150/jca.57926] [Reference Citation Analysis]
119 Kim H, Son S, Ko Y, Shin I. CTGF regulates cell proliferation, migration, and glucose metabolism through activation of FAK signaling in triple-negative breast cancer. Oncogene 2021;40:2667-81. [PMID: 33692467 DOI: 10.1038/s41388-021-01731-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
120 Scalise M, Console L, Galluccio M, Pochini L, Tonazzi A, Giangregorio N, Indiveri C. Exploiting Cysteine Residues of SLC Membrane Transporters as Targets for Drugs. SLAS Discov 2019;24:867-81. [PMID: 31251685 DOI: 10.1177/2472555219856601] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
121 Chen CH, Wang BW, Hsiao YC, Wu CY, Cheng FJ, Hsia TC, Chen CY, Wang Y, Weihua Z, Chou RH, Tang CH, Chen YJ, Wei YL, Hsu JL, Tu CY, Hung MC, Huang WC. PKCδ-mediated SGLT1 upregulation confers the acquired resistance of NSCLC to EGFR TKIs. Oncogene 2021;40:4796-808. [PMID: 34155348 DOI: 10.1038/s41388-021-01889-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
122 Mamun AA, Hayashi H, Yamamura A, Nayeem MJ, Sato M. Hypoxia induces the translocation of glucose transporter 1 to the plasma membrane in vascular endothelial cells. J Physiol Sci 2020;70:44. [PMID: 32962633 DOI: 10.1186/s12576-020-00773-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
123 Yao X, He Z, Qin C, Deng X, Bai L, Li G, Shi J. SLC2A3 promotes macrophage infiltration by glycolysis reprogramming in gastric cancer. Cancer Cell Int 2020;20:503. [PMID: 33061855 DOI: 10.1186/s12935-020-01599-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
124 Lauer V, Grampp S, Platt J, Lafleur V, Lombardi O, Choudhry H, Kranz F, Hartmann A, Wullich B, Yamamoto A, Coleman ML, Ratcliffe PJ, Mole DR, Schödel J. Hypoxia drives glucose transporter 3 expression through hypoxia-inducible transcription factor (HIF)-mediated induction of the long noncoding RNA NICI. J Biol Chem 2020;295:4065-78. [PMID: 31690629 DOI: 10.1074/jbc.RA119.009827] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
125 Zang X, Cheng M, Zhang X, Chen X. Quercetin nanoformulations: a promising strategy for tumor therapy. Food Funct 2021;12:6664-81. [PMID: 34152346 DOI: 10.1039/d1fo00851j] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Daly CA, Smit MJ, Plouffe B. The constitutive activity of the viral-encoded G protein-coupled receptor US28 supports a complex signalling network contributing to cancer development. Biochem Soc Trans 2020;48:1493-504. [PMID: 32779712 DOI: 10.1042/BST20190988] [Reference Citation Analysis]
127 Contat C, Ancey PB, Zangger N, Sabatino S, Pascual J, Escrig S, Jensen L, Goepfert C, Lanz B, Lepore M, Gruetter R, Rossier A, Berezowska S, Neppl C, Zlobec I, Clerc-Rosset S, Knott GW, Rathmell JC, Abel ED, Meibom A, Meylan E. Combined deletion of Glut1 and Glut3 impairs lung adenocarcinoma growth. Elife 2020;9:e53618. [PMID: 32571479 DOI: 10.7554/eLife.53618] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
128 Kim G, Lim S, Kim KD. N-myc Downstream-Regulated Gene 2 (NDRG2) Function as a Positive Regulator of Apoptosis: A New Insight into NDRG2 as a Tumor Suppressor. Cells 2021;10:2649. [PMID: 34685629 DOI: 10.3390/cells10102649] [Reference Citation Analysis]
129 Liu C, Li X. Greasy GLUT1 maintains glioblastoma malignancy. Molecular & Cellular Oncology 2021;8:2009423. [DOI: 10.1080/23723556.2021.2009423] [Reference Citation Analysis]
130 Akao Y, Kuranaga Y, Heishima K, Sugito N, Morikawa K, Ito Y, Soga T, Ito T. Plant hvu-MIR168-3p enhances expression of glucose transporter 1 (SLC2A1) in human cells by silencing genes related to mitochondrial electron transport chain complex I. J Nutr Biochem 2021;101:108922. [PMID: 34856354 DOI: 10.1016/j.jnutbio.2021.108922] [Reference Citation Analysis]
131 Drew D, North RA, Nagarathinam K, Tanabe M. Structures and General Transport Mechanisms by the Major Facilitator Superfamily (MFS). Chem Rev 2021;121:5289-335. [PMID: 33886296 DOI: 10.1021/acs.chemrev.0c00983] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
132 Lu YY, Wu CH, Hong CH, Chang KL, Lee CH. GLUT-1 Enhances Glycolysis, Oxidative Stress, and Fibroblast Proliferation in Keloid. Life (Basel) 2021;11:505. [PMID: 34070830 DOI: 10.3390/life11060505] [Reference Citation Analysis]
133 Liu XS, Gao Y, Wu LB, Wan HB, Yan P, Jin Y, Guo SB, Wang YL, Chen XQ, Zhou LM, Yang JW, Kui XY, Liu XY, Pei ZJ. Comprehensive Analysis of GLUT1 Immune Infiltrates and ceRNA Network in Human Esophageal Carcinoma. Front Oncol 2021;11:665388. [PMID: 34123828 DOI: 10.3389/fonc.2021.665388] [Reference Citation Analysis]
134 Hoxhaj G, Manning BD. The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nat Rev Cancer 2020;20:74-88. [PMID: 31686003 DOI: 10.1038/s41568-019-0216-7] [Cited by in Crossref: 235] [Cited by in F6Publishing: 248] [Article Influence: 78.3] [Reference Citation Analysis]
135 Kobayashi A, Waku T. New addiction to the NRF2-related factor NRF3 in cancer cells: Ubiquitin-independent proteolysis through the 20S proteasome. Cancer Sci 2020;111:6-14. [PMID: 31742837 DOI: 10.1111/cas.14244] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
136 Yu G, Li S, Wei R, Jiang Z, Chiefari E. Diabetes and Colorectal Cancer Risk: Clinical and Therapeutic Implications. Journal of Diabetes Research 2022;2022:1-16. [DOI: 10.1155/2022/1747326] [Reference Citation Analysis]
137 Liu C, He S, Zhang J, Li S, Chen J, Han C. Silencing TCF4 Sensitizes Melanoma Cells to Vemurafenib Through Inhibiting GLUT3-Mediated Glycolysis. Onco Targets Ther 2020;13:4905-15. [PMID: 32581551 DOI: 10.2147/OTT.S245531] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
138 Behl T, Sehgal A, Grover M, Singh S, Sharma N, Bhatia S, Al-Harrasi A, Aleya L, Bungau S. Uncurtaining the pivotal role of ABC transporters in diabetes mellitus. Environ Sci Pollut Res Int 2021;28:41533-51. [PMID: 34085197 DOI: 10.1007/s11356-021-14675-y] [Reference Citation Analysis]
139 Torres-Pérez SA, Torres-Pérez CE, Pedraza-Escalona M, Pérez-Tapia SM, Ramón-Gallegos E. Glycosylated Nanoparticles for Cancer-Targeted Drug Delivery. Front Oncol 2020;10:605037. [PMID: 33330106 DOI: 10.3389/fonc.2020.605037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
140 Kooshki L, Mahdavi P, Fakhri S, Akkol EK, Khan H. Targeting lactate metabolism and glycolytic pathways in the tumor microenvironment by natural products: A promising strategy in combating cancer. Biofactors 2021. [PMID: 34724274 DOI: 10.1002/biof.1799] [Reference Citation Analysis]
141 Samec M, Liskova A, Koklesova L, Samuel SM, Zhai K, Buhrmann C, Varghese E, Abotaleb M, Qaradakhi T, Zulli A, Kello M, Mojzis J, Zubor P, Kwon TK, Shakibaei M, Büsselberg D, Sarria GR, Golubnitschaja O, Kubatka P. Flavonoids against the Warburg phenotype-concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism. EPMA J 2020;11:377-98. [PMID: 32843908 DOI: 10.1007/s13167-020-00217-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 16.0] [Reference Citation Analysis]
142 Yu L, Ji KY, Zhang J, Xu Y, Ying Y, Mai T, Xu S, Zhang QB, Yao KT, Xu Y. Core pluripotency factors promote glycolysis of human embryonic stem cells by activating GLUT1 enhancer. Protein Cell 2019;10:668-80. [PMID: 31152430 DOI: 10.1007/s13238-019-0637-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
143 Charkhat Gorgich EA, Arbabi P, Parsaie H. Active Tumor-Targeting by Smart Nanocarriers: A Potential Promising Approach to Overcome the Hurdles of Conventional Cancer Treatments. Asian Pac J Cancer Prev 2021;22:1331-2. [PMID: 34048160 DOI: 10.31557/APJCP.2021.22.5.1331] [Reference Citation Analysis]
144 Baczewska M, Bojczuk K, Kołakowski A, Dobroch J, Guzik P, Knapp P. Obesity and Energy Substrate Transporters in Ovarian Cancer-Review. Molecules 2021;26:1659. [PMID: 33809784 DOI: 10.3390/molecules26061659] [Reference Citation Analysis]
145 Moldogazieva NT, Mokhosoev IM, Terentiev AA. Metabolic Heterogeneity of Cancer Cells: An Interplay between HIF-1, GLUTs, and AMPK. Cancers (Basel) 2020;12:E862. [PMID: 32252351 DOI: 10.3390/cancers12040862] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 14.0] [Reference Citation Analysis]
146 Reyes A, Duarte LF, Farías MA, Tognarelli E, Kalergis AM, Bueno SM, González PA. Impact of Hypoxia over Human Viral Infections and Key Cellular Processes. Int J Mol Sci 2021;22:7954. [PMID: 34360716 DOI: 10.3390/ijms22157954] [Reference Citation Analysis]
147 Montrose DC, Galluzzi L. Drugging cancer metabolism: Expectations vs. reality. Int Rev Cell Mol Biol 2019;347:1-26. [PMID: 31451211 DOI: 10.1016/bs.ircmb.2019.07.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
148 Michalek S, Brunner T. Nuclear-mitochondrial crosstalk: On the role of the nuclear receptor liver receptor homolog-1 (NR5A2) in the regulation of mitochondrial metabolism, cell survival, and cancer. IUBMB Life 2021;73:592-610. [PMID: 32931651 DOI: 10.1002/iub.2386] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
149 Pham DV, Park PH. Tumor Metabolic Reprogramming by Adipokines as a Critical Driver of Obesity-Associated Cancer Progression. Int J Mol Sci 2021;22:1444. [PMID: 33535537 DOI: 10.3390/ijms22031444] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
150 Suwabe Y, Nakano R, Namba S, Yachiku N, Kuji M, Sugimura M, Kitanaka N, Kitanaka T, Konno T, Sugiya H, Nakayama T. Involvement of GLUT1 and GLUT3 in the growth of canine melanoma cells. PLoS One 2021;16:e0243859. [PMID: 33539362 DOI: 10.1371/journal.pone.0243859] [Reference Citation Analysis]
151 Chen J, Cao L, Li Z, Li Y. SIRT1 promotes GLUT1 expression and bladder cancer progression via regulation of glucose uptake. Hum Cell 2019;32:193-201. [PMID: 30868406 DOI: 10.1007/s13577-019-00237-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
152 Woźniak M, Makuch S, Pastuch-Gawołek G, Wiśniewski J, Szeja W, Nowak M, Krawczyk M, Agrawal S. The Effect of a New Glucose-Methotrexate Conjugate on Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma Cell Lines. Molecules 2021;26:2547. [PMID: 33925555 DOI: 10.3390/molecules26092547] [Reference Citation Analysis]
153 Do SK, Choi SH, Lee SY, Choi JE, Hong MJ, Kang H, Lee WK, Lee EB, Shin KM, Jeong JY, Lee YH, Seo H, Yoo SS, Lee J, Cha SI, Kim CH, Seok Y, Cho S, Jheon S, Park JY. Glucose transporter 3 gene variant is associated with survival outcome of patients with non-small cell lung cancer after surgical resection. Gene 2019;703:58-64. [DOI: 10.1016/j.gene.2019.04.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
154 Schmidl S, Tamayo Rojas SA, Iancu CV, Choe JY, Oreb M. Functional Expression of the Human Glucose Transporters GLUT2 and GLUT3 in Yeast Offers Novel Screening Systems for GLUT-Targeting Drugs. Front Mol Biosci 2020;7:598419. [PMID: 33681287 DOI: 10.3389/fmolb.2020.598419] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
155 Huang L, He C, Zheng S, Wu C, Ren M, Shan Y. AKT1/HK2 Axis-mediated Glucose Metabolism: A Novel Therapeutic Target of Sulforaphane in Bladder Cancer. Mol Nutr Food Res 2021;:e2100738. [PMID: 34791822 DOI: 10.1002/mnfr.202100738] [Reference Citation Analysis]
156 Huang P, Zhu S, Liang X, Zhang Q, Luo X, Liu C, Song L. Regulatory Mechanisms of LncRNAs in Cancer Glycolysis: Facts and Perspectives. Cancer Manag Res 2021;13:5317-36. [PMID: 34262341 DOI: 10.2147/CMAR.S314502] [Reference Citation Analysis]
157 Mullapudi SS, Mitra D, Li M, Kang E, Chiong E, Neoh KG. Potentiating anti-cancer chemotherapeutics and antimicrobials via sugar-mediated strategies. Mol Syst Des Eng 2020;5:772-91. [DOI: 10.1039/c9me00175a] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
158 Zhang Y, Du H, Li Y, Yuan Y, Chen B, Sun S. Elevated TRIM23 expression predicts cisplatin resistance in lung adenocarcinoma. Cancer Sci 2020;111:637-46. [PMID: 31677335 DOI: 10.1111/cas.14226] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
159 Osaki T, Hibino S, Yokoe I, Yamaguchi H, Nomoto A, Yano S, Mikata Y, Tanaka M, Kataoka H, Okamoto Y. A Basic Study of Photodynamic Therapy with Glucose-Conjugated Chlorin e6 Using Mammary Carcinoma Xenografts. Cancers (Basel) 2019;11:E636. [PMID: 31071967 DOI: 10.3390/cancers11050636] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
160 Casiraghi A, Bensimon A, Superti-Furga G. Recent developments in ligands and chemical probes targeting solute carrier transporters. Curr Opin Chem Biol 2021;62:53-63. [PMID: 33689964 DOI: 10.1016/j.cbpa.2021.01.012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
161 D'Angelo E, Lindoso RS, Sensi F, Pucciarelli S, Bussolati B, Agostini M, Collino F. Intrinsic and Extrinsic Modulators of the Epithelial to Mesenchymal Transition: Driving the Fate of Tumor Microenvironment. Front Oncol 2020;10:1122. [PMID: 32793478 DOI: 10.3389/fonc.2020.01122] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
162 Han X, Raun SH, Carlsson M, Sjøberg KA, Henriquez-Olguín C, Ali M, Lundsgaard AM, Fritzen AM, Møller LLV, Li Z, Li J, Jensen TE, Kiens B, Sylow L. Cancer causes metabolic perturbations associated with reduced insulin-stimulated glucose uptake in peripheral tissues and impaired muscle microvascular perfusion. Metabolism 2020;105:154169. [PMID: 31987858 DOI: 10.1016/j.metabol.2020.154169] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
163 Edemir B. Identification of Prognostic Organic Cation and Anion Transporters in Different Cancer Entities by In Silico Analysis. Int J Mol Sci 2020;21:E4491. [PMID: 32599841 DOI: 10.3390/ijms21124491] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
164 Aono S, Hatanaka A, Hatanaka A, Gao Y, Hippo Y, Taketo MM, Waku T, Kobayashi A. β-Catenin/TCF4 Complex-Mediated Induction of the NRF3 (NFE2L3) Gene in Cancer Cells. Int J Mol Sci 2019;20:E3344. [PMID: 31288376 DOI: 10.3390/ijms20133344] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
165 Liu X, Yang J, Zeng J, Chen X, Gao Y, Kui X, Liu X, Zhang Y, Zhang Y, Pei Z. SLC2A1 is a Diagnostic Biomarker Involved in Immune Infiltration of Colorectal Cancer and Associated With m6A Modification and ceRNA. Front Cell Dev Biol 2022;10:853596. [DOI: 10.3389/fcell.2022.853596] [Reference Citation Analysis]
166 Garlapati C, Joshi S, Turaga RC, Mishra M, Reid MD, Kapoor S, Artinian L, Rehder V, Aneja R. Monoethanolamine-induced glucose deprivation promotes apoptosis through metabolic rewiring in prostate cancer. Theranostics 2021;11:9089-106. [PMID: 34522228 DOI: 10.7150/thno.62724] [Reference Citation Analysis]
167 Filippi L, Frantellizzi V, Chiaravalloti A, Pontico M, De Feo MS, Corica F, Montebello M, Schillaci O, De Vincentis G, Bagni O. Prognostic and Theranostic Applications of Positron Emission Tomography for a Personalized Approach to Metastatic Castration-Resistant Prostate Cancer. Int J Mol Sci 2021;22:3036. [PMID: 33809749 DOI: 10.3390/ijms22063036] [Reference Citation Analysis]
168 McGuirk S, Audet-Delage Y, St-Pierre J. Metabolic Fitness and Plasticity in Cancer Progression. Trends Cancer 2020;6:49-61. [PMID: 31952781 DOI: 10.1016/j.trecan.2019.11.009] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 15.0] [Reference Citation Analysis]
169 Al Tameemi W, Dale TP, Al-Jumaily RMK, Forsyth NR. Hypoxia-Modified Cancer Cell Metabolism. Front Cell Dev Biol 2019;7:4. [PMID: 30761299 DOI: 10.3389/fcell.2019.00004] [Cited by in Crossref: 131] [Cited by in F6Publishing: 121] [Article Influence: 43.7] [Reference Citation Analysis]
170 Abbaszadeh Z, Çeşmeli S, Biray Avcı Ç. Crucial players in glycolysis: Cancer progress. Gene 2020;726:144158. [PMID: 31629815 DOI: 10.1016/j.gene.2019.144158] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
171 Chandel V, Raj S, Kumar P, Gupta S, Dhasmana A, Kesari KK, Ruokolainen J, Mehra P, Das BC, Kamal MA, Kumar D. Metabolic regulation in HPV associated head and neck squamous cell carcinoma. Life Sci 2020;258:118236. [PMID: 32795537 DOI: 10.1016/j.lfs.2020.118236] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
172 Zhang Y, Wang Y, Li Y, Huang C, Xiao X, Zhong Z, Tang J, Lu H, Tang Y, Yang J. Dihydroartemisinin and Artesunate Inhibit Aerobic Glycolysis via Suppressing c-Myc Signaling in non-small Cell Lung Cancer. Biochem Pharmacol 2022;:114941. [PMID: 35149053 DOI: 10.1016/j.bcp.2022.114941] [Reference Citation Analysis]
173 Sebestyén A, Dankó T, Sztankovics D, Moldvai D, Raffay R, Cervi C, Krencz I, Zsiros V, Jeney A, Petővári G. The role of metabolic ecosystem in cancer progression — metabolic plasticity and mTOR hyperactivity in tumor tissues. Cancer Metastasis Rev. [DOI: 10.1007/s10555-021-10006-2] [Reference Citation Analysis]
174 Zhou L, Xu G, Wang L, Zhang J, Li W. Derivation of a Novel CIHI in Patients with Lung Adenocarcinoma for Estimating Tumor Microenvironment and Clinical Prognosis. Dis Markers 2021;2021:4495489. [PMID: 34853621 DOI: 10.1155/2021/4495489] [Reference Citation Analysis]